| Host |
Sheep |
| Klon |
polyclonal |
| Format |
FITC |
| Methode |
F, FL |
| Verdünnung |
1:20 - 1:100 |
| Isotyp |
Sheep IgG |
| Verdünnung |
Purified bovine IgG2 |
IgG2, Bovine - FITC
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
FITC |
RUO |
609-0469C |
-
|
| Host |
Sheep |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
1:10.000 - 1:100.000 |
| Isotyp |
Sheep IgG |
| Verdünnung |
Purified bovine IgG2 |
IgG2, Bovine - HRP
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0470D |
-
|
| Host |
Sheep |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
F, EL, WB |
| Isotyp |
Sheep IgG |
IgG2, Canine
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0475 |
-
|
| Host |
Sheep |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
F, EL, WB |
| Isotyp |
Sheep IgG |
IgG2, Canine - HRP
|
Zytomed Systems GmbH |
polyclonal |
1 mg |
Purified |
RUO |
609-0477D |
-
|
| Host |
Mouse |
| Klon |
3C7 |
| Format |
Purified |
| Methode |
EL |
| Isotyp |
Mouse IgG2a |
| Verdünnung |
Human IgG from pooled serum |
IgG2, Human
|
Zytomed Systems GmbH |
3C7 |
500 µg |
Purified |
RUO |
609-0478 |
-
|
| Host |
Mouse |
| Klon |
HP6014 |
| Format |
Purified |
| Methode |
F, EL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Purified human IgG2 |
IgG2, Human
|
Zytomed Systems GmbH |
HP6014 |
200 µg |
Purified |
RUO |
609-0479 |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-9 |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
5 µg/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG2a from BALB/c mice |
IgG2a Heavy Chain, Mouse
|
Zytomed Systems GmbH |
LO-MG2a-9 |
1 mg |
Purified |
RUO |
609-0484 |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-7 |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
5 µg/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG from BALB/c mice |
IgG2a Heavy Chain, Mouse
|
Zytomed Systems GmbH |
LO-MG2a-7 |
250 µg |
Purified |
RUO |
609-0485 |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-7 |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
0,5 - 1 µg/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG from BALB/c mice |
IgG2a Heavy Chain, Mouse - Biotin
|
Zytomed Systems GmbH |
LO-MG2a-7 |
500 µg |
Purified |
RUO |
609-0487B |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-9 |
| Format |
Purified |
| Methode |
FL |
| Verdünnung |
5 µg/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG2a from BALB/c mice |
IgG2a Heavy Chain, Mouse - FITC
|
Zytomed Systems GmbH |
LO-MG2a-9 |
500 µg |
Purified |
RUO |
609-0488C |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-7 |
| Format |
Purified |
| Methode |
FL |
| Verdünnung |
5 µg/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG from BALB/c mice |
IgG2a Heavy Chain, Mouse - FITC
|
Zytomed Systems GmbH |
LO-MG2a-7 |
500 µg |
Purified |
RUO |
609-0489C |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-9 |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
250 ng/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG2a from BALB/c mice |
IgG2a Heavy Chain, Mouse - HRP
|
Zytomed Systems GmbH |
LO-MG2a-9 |
500 µg |
Purified |
RUO |
609-0490D |
-
|
| Host |
Rat |
| Klon |
LO-MG2a-7 |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
0,5 µg/mL |
| Isotyp |
Rat IgG1 |
| Verdünnung |
Purified IgG from BALB/c mice |
IgG2a Heavy Chain, Mouse - HRP
|
Zytomed Systems GmbH |
LO-MG2a-7 |
500 µg |
Purified |
RUO |
609-0491D |
-
|
| Host |
Mouse |
| Klon |
MARG2a-1 |
| Format |
Purified |
| Methode |
EL |
| Verdünnung |
1,25 µg/mL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Polyclonal rat IgG2a |
IgG2a Heavy Chain, Rat
|
Zytomed Systems GmbH |
MARG2a-1 |
250 µg |
Purified |
RUO |
609-0492 |
-
|
| Host |
Rabbit |
| Klon |
ZR299 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Recombinant full-length human IGHG4 protein |
| Lokalisation |
Cytoplasm |
IgG4
|
Zeta Corporation |
ZR299 |
1 ml |
Concentrate |
CE/IVD |
Z2614RL |
-
|
| Host |
Rabbit |
| Klon |
ZR299 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
IgG |
| Verdünnung |
Recombinant full-length human IGHG4 protein |
| Lokalisation |
Cytoplasm |
IgG4
|
Zeta Corporation |
ZR299 |
7 ml |
Ready-to-use |
CE/IVD |
Z2614RP |
-
|
| Host |
Rabbit |
| Klon |
ZR299 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Recombinant full-length human IGHG4 protein |
| Lokalisation |
Cytoplasm |
IgG4
|
Zeta Corporation |
ZR299 |
0.5 ml |
Concentrate |
CE/IVD |
Z2614RS |
-
|
| Host |
Rabbit |
| Klon |
ZR299 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Recombinant full-length human IGHG4 protein |
| Lokalisation |
Cytoplasm |
IgG4
|
Zeta Corporation |
ZR299 |
0.1 ml |
Concentrate |
CE/IVD |
Z2614RT |
-
|
| Host |
Mouse |
| Klon |
HP6025 |
| Format |
Purified |
| Methode |
F |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Purified IgG4 |
IgG4, Human
|
Zytomed Systems GmbH |
HP6025 |
200 µg |
Purified |
RUO |
609-0564 |
-
|
| Host |
Rabbit |
| Klon |
ZR249 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Heavy chain of human IgM |
| Lokalisation |
Cytoplasm, cell surface and secreted |
IgM
|
Zeta Corporation |
ZR249 |
1 ml |
Concentrate |
CE/IVD |
Z2723RL |
-
|
| Host |
Rabbit |
| Klon |
ZR249 |
| Format |
r-t-u |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node |
| Verdünnung |
- |
| Isotyp |
IgG |
| Verdünnung |
Heavy chain of human IgM |
| Lokalisation |
Cytoplasm, cell surface and secreted |
IgM
|
Zeta Corporation |
ZR249 |
7 ml |
r-t-u |
CE/IVD |
Z2723RP |
-
|
| Host |
Rabbit |
| Klon |
ZR249 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Heavy chain of human IgM |
| Lokalisation |
Cytoplasm, cell surface and secreted |
IgM
|
Zeta Corporation |
ZR249 |
0.5 ml |
Concentrate |
CE/IVD |
Z2723RS |
-
|
| Host |
Rabbit |
| Klon |
ZR249 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Heavy chain of human IgM |
| Lokalisation |
Cytoplasm, cell surface and secreted |
IgM
|
Zeta Corporation |
ZR249 |
0.1 ml |
Concentrate |
CE/IVD |
Z2723RT |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Verdünnung |
1:20 - 1:40 |
| Isotyp |
Rabbit Ig |
IgM-FITC
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
F009 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Verdünnung |
1:20 - 1:40 |
| Isotyp |
Rabbit Ig |
IgM-FITC
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
F009-01 |
-
|
| Host |
Mouse |
| Klon |
R1/69 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
proteolytic |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
IgG1 kappa |
| Verdünnung |
purified human IgM |
| Lokalisation |
Cytoplasm |
IgM, human
|
Diagnostic Biosystems |
R1/69 |
1 ml |
Concentrate |
CE/IVD |
MOB074 |
-
|
| Host |
Mouse |
| Klon |
R1/69 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
proteolytic |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
IgG1 kappa |
| Verdünnung |
purified human IgM |
| Lokalisation |
Cytoplasm |
IgM, human
|
Diagnostic Biosystems |
R1/69 |
0.1 ml |
Concentrate |
CE/IVD |
MOB074-01 |
-
|
| Host |
Mouse |
| Klon |
R1/69 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
proteolytic |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
IgG1 kappa |
| Verdünnung |
purified human IgM |
| Lokalisation |
Cytoplasm |
IgM, human
|
Diagnostic Biosystems |
R1/69 |
0.5 ml |
Concentrate |
CE/IVD |
MOB074-05 |
-
|
| Host |
Mouse |
| Klon |
R1/69 |
| Format |
Ready-to-use |
| Methode |
P |
| Vorbehandlung |
proteolytic |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
IgG1 kappa |
| Verdünnung |
purified human IgM |
| Lokalisation |
Cytoplasm |
IgM, human
|
Diagnostic Biosystems |
R1/69 |
6 ml |
Ready-to-use |
CE/IVD |
PDM053 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Ready-to-use |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
IgM, Human
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR019 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:50 - 1:250 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
IgM, Human
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP024 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:50 - 1:250 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
IgM, Human
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP024-01 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:50 - 1:250 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
IgM, Human
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP024-05 |
-
|
| Host |
Rabbit |
| Klon |
SP108 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit Ig |
| Verdünnung |
A synthetic peptide derived from near N-terminus of human IKAROS protein |
| Lokalisation |
Nucleus |
IKAROS
|
Zytomed Systems GmbH |
SP108 |
1 ml |
Concentrate |
RUO |
509-4084 |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex. |
| Verdünnung |
1:10 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide corresponding to aa1-32 of human inhibin alpha subunit |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
R1 |
1.0 ml |
Concentrate |
CE/IVD |
Z2115ML |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex. |
| Verdünnung |
- |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide corresponding to aa1-32 of human inhibin alpha subunit |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
R1 |
7 ml |
Ready-to-use |
CE/IVD |
Z2115MP |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex. |
| Verdünnung |
1:10 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide corresponding to aa1-32 of human inhibin alpha subunit |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
R1 |
0.5 ml |
Concentrate |
CE/IVD |
Z2115MS |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex. |
| Verdünnung |
1:10 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide corresponding to aa1-32 of human inhibin alpha subunit |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
R1 |
0.1 ml |
Concentrate |
CE/IVD |
Z2115MT |
-
|
| Host |
Mouse |
| Klon |
ZM113 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex, testis, corpus luteum |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide (around aa 73-¬96) of α-subunit of human inhibin A protein |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
ZM113 |
1 ml |
Concentrate |
CE/IVD |
Z2413ML |
-
|
| Host |
Mouse |
| Klon |
ZM113 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex, testis, corpus luteum |
| Verdünnung |
- |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide (around aa 73-¬96) of α-subunit of human inhibin A protein |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
ZM113 |
7 ml |
Ready-to-use |
CE/IVD |
Z2413MP |
-
|
| Host |
Mouse |
| Klon |
ZM113 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex, testis, corpus luteum |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide (around aa 73-¬96) of α-subunit of human inhibin A protein |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
ZM113 |
0.5 ml |
Concentrate |
CE/IVD |
Z2413MS |
-
|
| Host |
Mouse |
| Klon |
ZM113 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Adrenal cortex, testis, corpus luteum |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
A synthetic peptide (around aa 73-¬96) of α-subunit of human inhibin A protein |
| Lokalisation |
Cytoplasm |
Inhibin-α
|
Zeta Corporation |
ZM113 |
0.1 ml |
Concentrate |
CE/IVD |
Z2413MT |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Ovary |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm |
Inhibin alpha
|
Diagnostic Biosystems |
R1 |
1 ml |
Concentrate |
CE/IVD |
MOB435 |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Ovary |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm |
Inhibin alpha
|
Diagnostic Biosystems |
R1 |
0.1 ml |
Concentrate |
CE/IVD |
MOB435-01 |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Ovary |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm |
Inhibin alpha
|
Diagnostic Biosystems |
R1 |
0.5 ml |
Concentrate |
CE/IVD |
MOB435-05 |
-
|
| Host |
Mouse |
| Klon |
R1 |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Ovary |
| Verdünnung |
- |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm |
Inhibin alpha
|
Diagnostic Biosystems |
R1 |
6 ml |
Ready-to-use |
CE/IVD |
PDM178 |
-
|
| Host |
Mouse |
| Klon |
25.0 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Brain or astrocytoma. |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
Mouse BAF47 aa 257-359 |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
25.0 |
1.0 ml |
Concentrate |
CE/IVD |
Z2177ML |
-
|
| Host |
Mouse |
| Klon |
25.0 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Brain or astrocytoma. |
| Verdünnung |
- |
| Isotyp |
IgG2a /κ |
| Verdünnung |
Mouse BAF47 aa 257-359 |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
25.0 |
7 ml |
Ready-to-use |
CE/IVD |
Z2177MP |
-
|
| Host |
Mouse |
| Klon |
25.0 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Brain or astrocytoma. |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
Mouse BAF47 aa 257-359 |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
25.0 |
0.5 ml |
Concentrate |
CE/IVD |
Z2177MS |
-
|
| Host |
Mouse |
| Klon |
25.0 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Brain or astrocytoma. |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
IgG2a /κ |
| Verdünnung |
Mouse BAF47 aa 257-359 |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
25.0 |
0.1 ml |
Concentrate |
CE/IVD |
Z2177MT |
-
|